Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DIAGNOSTIC INDUSTRY SHIFT TO INCREMENTAL PRODUCT IMPROVEMENTS

This article was originally published in The Gray Sheet

Executive Summary

DIAGNOSTIC INDUSTRY SHIFT TO INCREMENTAL PRODUCT IMPROVEMENTS rather than breakthrough advances is foreseen by Miles Diagnostics Executive VP for Worldwide Marketing, Sales and Service Rolf Classon. Addressing a meeting of the American Association for Clinical Chemistry on March 15, Classon said uncertainty due to health care reform and the movement toward managed care in health care delivery has facilitated a "change...not on the amount [diagnostics manufacturers] spend on research and development, but how we apply it."
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel